FS20/2: Patient Capital and Authorised Funds

The Financial Conduct Authority issued this feedback statement to address comments received on its earlier discussion paper regarding patient capital and authorised funds. The document outlines the regulator's final decisions and clarifications on how these concepts apply to the UK fund industry. It serves as the concluding record of the consultation process initiated in December 2018 and closed in February 2019.

United Kingdom

Financial Conduct Authority

Show thumbnailShow full textSourceAdd to collection

Show full text

Open discussion: DP18/10

12/12/2018

Discussion closed

28/02/2019

Feedback Statement (FS20/2)

28/02/2020

28/02/2020